12:26 PM EST - Lorus Therapeutics Inc. : reported financial results for the three months ended November 30, 2010. Net loss for the period remained consistent at $1.3 million ($0.11 per share) compared to $1.3 million ($0.14 per share) in the same period in the prior year. In the three months, compared with the prior year, higher stock based compensation costs amounted to an expense of $31,000 in the current year compared with an $89,000 recovery in the prior year as well as revenue of $79,000 in the prior year compared with no revenue in the current year. Lorus Therapeutics Inc.
shares T.LOR are trading down $0.01 at $1.00.
